Induction of hyperglycemia in mice with atypical antipsychotic drugs that inhibit glucose uptake
Authors:
- 1 May 2003
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 75 (2) , 255-260
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonistsAmerican Journal of Physiology-Cell Physiology, 2002
- Hyperglycemic Clamp Assessment of Insulin Secretory Responses in Normal Subjects Treated with Olanzapine, Risperidone, or PlaceboThe Journal of Clinical Endocrinology & Metabolism, 2002
- Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapineBrain Research, 2001
- Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic StudyAmerican Journal of Psychiatry, 2000
- Drug Treatment of Schizophrenia in the 1990sDrugs, 1997
- Ketoacidosis as a side‐effect of clozapine: a case reportActa Psychiatrica Scandinavica, 1996
- Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteinsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
- Tardive DyskinesiaSchizophrenia Bulletin, 1993
- Ganglioside therapy of type I diabetes: Enhancement of hyperglycemia in the low dose streptozotocin modelLife Sciences, 1992
- Effects of the 5-HT1C/5-HT2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the ratEuropean Journal of Pharmacology, 1990